The DOI matches its Crossref record.
Down-regulation of Fc(ε)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody
Abstract
Treatment of allergic disease by decreasing circulating IgE with anti-IgE Abs is currently under clinical study. Based on previous unrelated studies, it appeared likely that Fc(ε)RI expression on basophils and mast cells might also be regulated by levels of circulating IgE Ab. Therefore, the expression of IgE and Fc(ε)RI on human basophils was examined in 15 subjects receiving humanized anti-IgE mAb intravenously. Treatment with the anti-IgE mAb decreased free IgE levels to 1% of pretreatment levels and also resulted in a marked down-regulation of Fc(ε)RI on basophils. Median pretreatment densities of Fc(ε)RI were approximately 220,000 receptors per basophil and after 3 mo of treatment, the densities had decreased to a median of 8,300 receptors per basophil. Flow cytometric studies, conducted in parallel, showed similar results and also showed in a subset of 3 donors that receptors decreased with a t1/2 of approximately 3 days. The responsiveness of the cells to IgE-mediated stimulation using anti-IgE Ab was marginally decreased (approximately 40%) while the response of the same cells to stimulation with dust mite Ag, Dermatophagoides farinae, was reduced by approximately 90%. One possible explanation for these results is that Fc(ε)RI density is directly or indirectly regulated by plasma-free IgE levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
IgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799
Allergy, Parasites, and the Hygiene Hypothesis
Yazdanbakhsh, M., Kremsner, P. G., & van Ree, R. (2002) · Science · doi:10.1126/science.296.5567.490 · Cited by 1,526
Kay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440106 · Cited by 1,368
Busse, W., Corren, J., Lanier, B. Q., McAlary, M., Fowler-Taylor, A., Cioppa, G. D., van As, A., & Gupta, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117880 · Cited by 1,307
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
Maurer, M., Rosén, K., Hsieh, H.-J., Saini, S., Grattan, C., Gimenéz-Arnau, A., Agarwal, S., Doyle, R., Canvin, J., Kaplan, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215372 · Cited by 1,105
The basic immunology of asthma
Hammad, H., & Lambrecht, B. N. (2021) · Cell · doi:10.1016/j.cell.2021.02.016 · Cited by 1,105
THE HIGH-AFFINITY I g E RECEPTOR (FcεRI): From Physiology to Pathology
Kinet, J.-P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.931 · Cited by 968
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
Busse, W. W., Morgan, W. J., Gergen, P. J., Mitchell, H. E., Gern, J. E., Liu, A. H., Gruchalla, R. S., Kattan, M., Teach, S. J., Pongracic, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009705 · Cited by 884
Self-citationTherapeutic antibodies for autoimmunity and inflammation
Chan, A. C., & Carter, P. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2761 · Cited by 837
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
Gevaert, P., Calus, L., Van Zele, T., Blomme, K., De Ruyck, N., Bauters, W., Hellings, P., Brusselle, G., De Bacquer, D., van Cauwenberge, P., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.047 · Cited by 744
Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody
Milgrom, H., Fick, R. B., Su, J. Q., Reimann, J. D., Bush, R. K., Watrous, M. L., & Metzger, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412603 · Cited by 704
Effect of Anti-IgE Therapy in Patients with Peanut Allergy
Leung, D. Y. M., Sampson, H. A., Yunginger, J. W., Burks, A. W., Schneider, L. C., Wortel, C. H., Davis, F. M., Hyun, J. D., & Shanahan, W. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022613 · Cited by 691
The Biology of IgE and the Basis of Allergic Disease
Gould, H. J., Sutton, B. J., Beavil, A. J., Beavil, R. L., McCloskey, N., Coker, H. A., Fear, D., & Smurthwaite, L. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141103 · Cited by 685
Djukanović, R., Wilson, S. J., Kraft, M., Jarjour, N. N., Steel, M., Chung, K. F., Bao, W., Fowler-Taylor, A., Matthews, J., Busse, W. W., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200312-1651oc · Cited by 646
Regulation of mast-cell and basophil function and survival by IgE
Kawakami, T., & Galli, S. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri914 · Cited by 633
New developments in FcεRI regulation, function and inhibition
Kraft, S., & Kinet, J.-P. (2007) · Nature Reviews Immunology · doi:10.1038/nri2072 · Cited by 579
Kaplan, A., Ledford, D., Ashby, M., Canvin, J., Zazzali, J. L., Conner, E., Veith, J., Kamath, N., Staubach, P., Jakob, T., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.013 · Cited by 573
Treatment of Childhood Asthma With Anti-Immunoglobulin E Antibody (Omalizumab)
Milgrom, H., Berger, W., Nayak, A., Gupta, N., Pollard, S., McAlary, M., Taylor, A. F., & Rohane, P. (2001) · Pediatrics · doi:10.1542/peds.108.2.e36 · Cited by 525
Galli, S. J. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200001000-00007 · Cited by 521
Food allergy. Part 2: Diagnosis and management
Sampson, H. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70167-3 · Cited by 495
Commonality of the IL-4/IL-13 pathway in atopic diseases
Gandhi, N. A., Pirozzi, G., & Graham, N. M. H. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1298443 · Cited by 493
IgE, Mast Cells, and Eosinophils in Atopic Dermatitis
Liu, F.-T., Goodarzi, H., & Chen, H.-Y. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8252-4 · Cited by 470
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
Holgate, S., Casale, T., Wenzel, S., Bousquet, J., Deniz, Y., & Reisner, C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.053 · Cited by 466
Omalizumab-induced reductions in mast cell FcεRI expression and function
Beck, L. A., Marcotte, G. V., MacGlashan, D., Togias, A., & Saini, S. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.032 · Cited by 456
Self-citationParasites and the Hygiene Hypothesis: Regulating the Immune System?
Yazdanbakhsh, M., & Matricardi, P. M. (2004) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:26:1:15 · Cited by 420
Vignola, A. M., Humbert, M., Bousquet, J., Boulet, L., Hedgecock, S., Blogg, M., Fox, H., & Surrey, K. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00550.x · Cited by 405
Saini, S., Rosen, K. E., Hsieh, H.-J., Wong, D. A., Conner, E., Kaplan, A., Spector, S., & Maurer, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.010 · Cited by 398
Lanier, B., Bridges, T., Kulus, M., Taylor, A. F., Berhane, I., & Vidaurre, C. F. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.021 · Cited by 360
The diverse potential effector and immunoregulatory roles of mast cells in allergic disease
Williams, C. M. M., & Galli, S. J. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.106485 · Cited by 355
Omalizumab treatment downregulates dendritic cell FcεRI expression
Prussin, C., Griffith, D. T., Boesel, K. M., Lin, H., Foster, B., & Casale, T. B. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.10.003 · Cited by 349
Roles of mast cells and basophils in innate and acquired immunity
Wedemeyer, J., Tsai, M., & Galli, S. J. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00154-0 · Cited by 345
Kuehr, J., Brauburger, J., Zielen, S., Schauer, U., Kamin, W., Von Berg, A., Leupold, W., Bergmann, K.-C., Rolinck-Werninghaus, C., Gräve, M., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121949 · Cited by 342
The role of allergen‐specific IgE, IgG and IgA in allergic disease
Shamji, M. H., Valenta, R., Jardetzky, T., Verhasselt, V., Durham, S. R., Würtzen, P. A., & van Neerven, R. J. J. (2021) · Allergy · doi:10.1111/all.14908 · Cited by 336
Kay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440206 · Cited by 321
Basophils and allergic inflammation
Siracusa, M. C., Kim, B. S., Spergel, J. M., & Artis, D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.046 · Cited by 313
Schneider, L. C., Rachid, R., LeBovidge, J., Blood, E., Mittal, M., & Umetsu, D. T. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.046 · Cited by 300
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria
Kaplan, A. P., Giménez-Arnau, A. M., & Saini, S. S. (2017) · Allergy · doi:10.1111/all.13083 · Cited by 293
The pharmacological basis of anti-IgE therapy
Chang, T. W. (2000) · Nature Biotechnology · doi:10.1038/72601 · Cited by 288
The human basophil: a new appreciation of its role in immune responses
Falcone, F. H., Haas, H., & Gibbs, B. F. (2000) · Blood · doi:10.1182/blood.v96.13.4028 · Cited by 269
Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils
Lin, H., Boesel, K. M., Griffith, D. T., Prussin, C., Foster, B., Romero, F. A., Townley, R., & Casale, T. B. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.11.044 · Cited by 269
Winthrop, K. L., Mariette, X., Silva, J. T., Benamu, E., Calabrese, L. H., Dumusc, A., Smolen, J. S., Aguado, J. M., & Fernández-Ruiz, M. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.02.002 · Cited by 259
Holgate, S. T., Djukanović, R., Casale, T., & Bousquet, J. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02191.x · Cited by 254
Future therapies for food allergies
Nowak-Węgrzyn, A., & Sampson, H. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1098 · Cited by 252
Massanari, M., Nelson, H., Casale, T., Busse, W., Kianifard, F., Geba, G. P., & Zeldin, R. K. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.022 · Cited by 230
Di Lorenzo, G., Mansueto, P., Pacor, M. L., Rizzo, M., Castello, F., Martinelli, N., Ditta, V., Lo Bianco, C., Leto-Barone, M. S., D'Alcamo, A., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.012 · Cited by 210
Failure of omalizumab for treatment of severe adult atopic dermatitis
Krathen, R. A., & Hsu, S. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.02.014 · Cited by 172
Klunker, S., Saggar, L. R., Seyfert-Margolis, V., Asare, A. L., Casale, T. B., Durham, S. R., & Francis, J. N. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.05.034 · Cited by 129
Basophil allergen threshold sensitivity: a useful approach to anti‐IgE treatment efficacy evaluation
Nopp, A., Johansson, S. G. O., Ankerst, J., Bylin, G., Cardell, L. O., Grönneberg, R., Irander, K., Palmqvist, M., & Öman, H. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.00987.x · Cited by 126
Cruz, A. A., Lima, F., Sarinho, E., Ayre, G., Martin, C., Fox, H., & Cooper, P. J. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02650.x · Cited by 111
Kopp, M. V., Brauburger, J., Riedinger, F., Beischer a, D., Ihorst, G., Kamin, W., Zielen, S., Bez, C., Friedrichs, F., von Berg, A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.128804 · Cited by 84
Revisiting the Roles of Mast Cells in Allergic Rhinitis and its Relation to Local IgE Synthesis
Pawankar, R., Yamagishi, S., & Yagi, T. (2000) · American Journal of Rhinology · doi:10.2500/105065800781329582 · Cited by 81
Omalizumab therapy for mast cell-mediator symptoms in patients with ISM, CM, MMAS, and MCAS
Lemal, R., Fouquet, G., Terriou, L., Vaes, M., Livideanu, C. B., Frenzel, L., Barete, S., Canioni, D., Lhermitte, L., Rossignol, J., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.03.039 · Cited by 70
Mast Cells in Allergic Airway Disease and Chronic Rhinosinusitis
Pawankar, R. (2005) · Chemical Immunology and Allergy · doi:10.1159/000087639 · Cited by 59
Management of asthma with anti-immunoglobulin E: A review of clinical trials of omalizumab
Nowak, D. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2005.10.004 · Cited by 59
Regulation of mouse mast cell surface FcεRI expression by dexamethasone
Yamaguchi, M., Hirai, K., Komiya, A., Miyamasu, M., Furumoto, Y., Teshima, R., Ohta, K., Morita, Y., Galli, S. J., Ra, C., et al. (2001) · International Immunology · doi:10.1093/intimm/13.7.843 · Cited by 42
Is there a role for anti-IgE in combination with specific allergen immunotherapy?
Hamelmann, E., Rolinck-Werninghaus, C., & Wahn, U. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200312000-00013 · Cited by 25
HAAK‐FRENDSCHO, SABAN†, SHIELDS, & JARDIEU (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00478.x · Cited by 18
Metadata
- Authors
- MacGlashan, D. W., Bochner, B. S., Adelman, D. C., Jardieu, P. M., Togias, A., McKenzie-White, J., Sterbinsky, S. A., Hamilton, R. G., & Lichtenstein, L. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-02-01
- Volume
- 158
- Issue
- 3
- Pages
- 1438-1445
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1910182345
- Cited by
- 823
- References
- 0
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.